FDA批准EpiPen的第一个通用版本

FDA批准EpiPen的第一个通用版本

美国食品和药物管理局已经批准了第一个与EpiPen相同的替代品,EpiPen广泛用于拯救患有危险过敏反应的儿童和成人。

美国食品和药品管理局周四授权Teva Pharmaceuticals USA为成人和体重超过33磅的儿童销售仿制版EpiPen和EpiPen Jr。

Shots – Health News : NPR

https://www.npr.org/sections/health-shots/2018/08/16/639317327/fda-approves-new-generic-version-of-the-epipen-for-allergic-reactions

Press Announcements > FDA approves first generic version of EpiPen

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617173.htm

Teva Gets FDA Nod for First Generic Version of Mylan’s EpiPen – August 17, 2018 – Zacks.com

https://www.zacks.com/stock/news/318432/teva-gets-fda-nod-for-first-generic-version-of-mylans-epipen?cid=CS-ZC-FT-318432

Mylan Teva EpiPen generic auto-injector market – Business Insider

https://www.businessinsider.com/mylan-teva-epipen-generic-auto-injector-market-2018-8?utm_source=feedly&utm_medium=referral